Mitral valve surgery using the classical 'heartport' technique

William H Ryan1, Todd M Dewey, Michael J Mack

  • 1Cardiopulmonary Research Science and Technology Institute, Dallas, Texas, USA.

Insights

Minimally invasive mitral valve surgery using the Heartport (HP) approach demonstrated comparable 30-day outcomes to conventional sternotomy (SP) despite longer cross-clamp times. This approach is safe and effective for mitral valve repair and replacement.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Mitral Valve Surgery

Background:

  • Minimally invasive mitral valve surgery via femoral cannulation and thoracotomy (Heartport - HP) is perceived as higher risk than conventional sternotomy (SP).
  • This study compares the operative risk and early outcomes of the initial 117 HP cases against a matched SP cohort.

Purpose of the Study:

  • To assess the operative risk and 30-day outcomes of mitral valve surgery performed using the Heartport (HP) approach.
  • To compare HP approach outcomes with conventional sternotomy (SP) in a matched patient cohort.

Main Methods:

  • Retrospective analysis of 117 patients undergoing mitral valve surgery via the Heartport (HP) approach (92 repairs, 25 replacements).
  • Patients were intention-to-treat and matched 1:1 to a sternotomy (SP) control group based on age, cerebrovascular disease, inotrope use, and ejection fraction.
  • Operative and 30-day outcomes were compared between the HP and SP groups.

Main Results:

  • No significant differences in 30-day outcomes were observed between the HP and SP groups.
  • The HP group experienced longer cross-clamp and perfusion times compared to the SP group.
  • Rare complications in the HP group included coronary sinus perforation requiring conversion in two cases, and one case aborted due to aortic dissection.

Conclusions:

  • The 'classical' Heartport (HP) approach for mitral valve surgery can be performed without increased operative risk compared to conventional sternotomy (SP), despite longer cross-clamp times.
  • Complications related to catheters and endoballoons were infrequent, even in early experience.
  • Conversion to sternotomy was uncommon and managed safely when necessary.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...